We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Figure 1

Figure 1. From: Elevated prevalence of obesity, metabolic syndrome, and cardiovascular risk factors in bipolar disorder.

Graphical illustration of metabolic syndrome estimates from current study (restricted sample) contrasted with published general population data. General population data from NHANES 1999–2000 was utilized to provide an expected estimate for our sample based on observed gender proportions. The age distribution of our sample was comparable to the NHANES sample of adults at least 20 years of age. Nearly double the expected prevalence of metabolic syndrome was observed. Prevalent users of the second generation antipsychotics (SGAs) most strongly associated with weight gain (clozapine, risperidone, olanzapine, and quetiapine) had a higher observed metabolic syndrome prevalence though this trend did not reach significance.

Jess G. Fiedorowicz, et al. Ann Clin Psychiatry. ;20(3):131-137.

Supplemental Content

Filter your results:

Search details

See more...

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Write to the Help Desk